2019年美国多州电子烟相关肺损伤暴发特征
在514例有症状前30天物质使用信息的患者中,76.9%报告使用含THC产品,56.8%报告使用含尼古丁产品;36.0%仅使用含THC产品,16.0%仅使用含尼古丁产品。具体致病化学暴露未知,CDC建议考虑避免使用电子烟或雾化产品,尤其是含THC的产品。
要点
- 截至2019年9月24日,美国报告805例电子烟相关肺损伤患者,12例死亡。
- 有物质使用信息的患者中,76.9%使用含THC产品,36.0%仅使用含THC产品。
核心结论
- 电子烟或雾化产品相关肺损伤暴发已波及美国多州,具体致病化学暴露尚不明确。
- CDC建议考虑避免使用电子烟或雾化产品,尤其是含THC的产品。
研究设计与样本
- 基于CDC多州持续调查的病例系列描述,截至2019年9月24日共报告805例患者。
主要发现
- 10个州确认12例死亡。
- 514例有症状前30天物质使用信息的患者中,76.9%报告使用含THC产品,56.8%报告使用含尼古丁产品。
- 36.0%报告仅使用含THC产品,16.0%报告仅使用含尼古丁产品。
临床怎么用
- 临床接诊电子烟或雾化产品使用者时,应询问症状前30天内的物质使用情况,包括THC和尼古丁产品。
- 建议公众考虑避免使用电子烟或雾化产品,尤其是含THC的产品。
局限性
- 具体致病化学暴露未知。
- 物质使用信息仅514例患者可得,存在信息不完整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Electronic cigarettes (e-cigarettes), also called vapes, e-hookas, vape pens, tank systems, mods, and electronic nicotine delivery systems (ENDS), are electronic devices that produce an aerosol by heating a liquid typically containing nicotine, flavorings, and other additives; users inhale this aerosol into their lungs (1). E-cigarettes also can be used to deliver tetrahydrocannabinol (THC), the principal psychoactive component of cannabis (1). Use of e-cigarettes is commonly called vaping. Lung injury associated with e-cigarette use, or vaping, has recently been reported in most states (2-4). CDC, the Food and Drug Administration (FDA), state and local health departments, and others are investigating this outbreak. This report provides data on patterns of the outbreak and characteristics of patients, including sex, age, and selected substances used in e-cigarette, or vaping, products reported to CDC as part of this ongoing multistate investigation. As of September 24, 2019, 46 state health departments and one territorial health department had reported 805 patients with cases of lung injury associated with use of e-cigarette, or vaping, products to CDC. Sixty-nine percent of patients were males, and the median age was 23 years (range = 13-72 years). To date, 12 deaths have been confirmed in 10 states. Among 514 patients with information on substances used in e-cigarettes, or vaping products, in the 30 days preceding symptom onset, 76.9% reported using THC-containing products, and 56.8% reported using nicotine-containing products; 36.0% reported exclusive use of THC-containing products, and 16.0% reported exclusive use of nicotine-containing products. The specific chemical exposure(s) causing the outbreak is currently unknown. While this investigation is ongoing, CDC recommends that persons consider refraining from using e-cigarette, or vaping, products, particularly those containing THC. CDC will continue to work in collaboration with FDA and state and local partners to investigate cases and advise and alert the public on the investigation as additional information becomes available.
引用
- Perrine CG, Pickens CM, Boehmer TK, et al. Characteristics of a Multistate Outbreak of Lung Injury Associated with E-cigarette Use, or Vaping - United States, 2019. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31581168. doi:10.15585/mmwr.mm6839e1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。